0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Clinical Trial Imaging Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-28U8971
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Clinical Trial Imaging Market Size Status and Forecast 2022
BUY CHAPTERS

Global Clinical Trial Imaging Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-28U8971
Report
June 2025
Pages:157
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Clinical Trial Imaging Market Size

In 2024, the global market size of Clinical Trial Imaging was estimated to be worth US$ 1569 million and is forecast to reach approximately US$ 2492 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.

Clinical Trial Imaging Market

Clinical Trial Imaging Market

Clinical trial imaging refers to the process of using imaging technology (such as X-ray, CT, MRI, etc.) to observe and analyze the subjects in vivo during clinical trials. It plays an irreplaceable role in evaluating the efficacy, safety and side effects of new drugs, treatments or medical devices. Through imaging technology, researchers can intuitively observe the distribution, metabolism and mechanism of action of drugs in the body, providing a scientific basis for the clinical application of drugs.
Global core clinical trial imaging manufacturers include Clario, ICON, McLaren, Calyx and BioTelemetry. The top 5 companies hold a share about 60%. North America is the largest market, with a share about 33%, followed by Europe and Asia Pacific both with the share about 27%. In terms of product, central imaging service is the largest segment, with a share about 70%. And in terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.
In the process of clinical trial imaging, ethical principles and regulatory requirements must be strictly followed. Researchers need to ensure that the informed consent rights of the subjects are fully protected and that scientific principles and ethical standards are strictly followed during the trial. At the same time, regulatory agencies also need to strengthen the supervision of clinical trial imaging to ensure the reliability and validity of the trial results.
Clinical trial imaging plays an important role at different stages of drug development. For example, in Phase I clinical trials, imaging technology can be used to observe the pharmacokinetic characteristics of drugs in the human body; in Phase II/III clinical trials, the efficacy and safety of drugs can be evaluated.
For new medical devices, clinical trial imaging can be used to evaluate their performance, safety and clinical application value. By comparing the effects of using new equipment with existing equipment, strong support can be provided for the promotion and application of medical equipment.
In clinical trials, imaging technology can also be used for early diagnosis of diseases, disease monitoring and treatment effect evaluation. For example, in tumor treatment, regular imaging examinations can be used to observe the size, morphology and changes of tumors, so as to adjust the treatment plan in time.
With the continuous advancement of medical technology and the increasing demand for clinical trials, the clinical trial imaging market will usher in a broader development prospect. In the future, this field will pay more attention to the development of technological innovation and personalized services to meet the needs of different clinical trials.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Clinical Trial Imaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Imaging.
The Clinical Trial Imaging market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Clinical Trial Imaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Trial Imaging companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Clinical Trial Imaging Market Report

Report Metric Details
Report Name Clinical Trial Imaging Market
Forecasted market size in 2031 approximately US$ 2492 million
CAGR 6.9%
Forecasted years 2025 - 2031
Segment by Type
  • In-house Imaging Service
  • Central Imaging Service
Segment by Application
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic Institutes
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company ICON, ERT, McLaren, Bioclinica, Parexel, BioTelemetry, ProScan Imaging, Imaging Endpoints, Radiant Sage, Micron, Inc., Intrinsic Imaging, Median Technologies, Cardiovascular Imaging Technologies, Banook Medical, IXICO, Tigermed, Runda Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Clinical Trial Imaging in global and regional level.
  • Chapter 3: Detailed analysis of Clinical Trial Imaging company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical Trial Imaging revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Clinical Trial Imaging Market size in 2031?

Ans: The Clinical Trial Imaging Market size in 2031 will be approximately US$ 2492 million.

What is the market share of major companies in Clinical Trial Imaging Market?

Ans: The top 5 companies hold a share about 60%.

What is the Clinical Trial Imaging Market share by type?

Ans: In terms of product, central imaging service is the largest segment, with a share about 70%.

Who are the main players in the Clinical Trial Imaging Market report?

Ans: The main players in the Clinical Trial Imaging Market are ICON, ERT, McLaren, Bioclinica, Parexel, BioTelemetry, ProScan Imaging, Imaging Endpoints, Radiant Sage, Micron, Inc., Intrinsic Imaging, Median Technologies, Cardiovascular Imaging Technologies, Banook Medical, IXICO, Tigermed, Runda Medical

What are the Application segmentation covered in the Clinical Trial Imaging Market report?

Ans: The Applications covered in the Clinical Trial Imaging Market report are Pharmaceutical Companies, Biotechnology Companies, Academic Institutes, Others

What are the Type segmentation covered in the Clinical Trial Imaging Market report?

Ans: The Types covered in the Clinical Trial Imaging Market report are In-house Imaging Service, Central Imaging Service

Recommended Reports

Clinical Imaging Markets

Medical Imaging Technology

Medical Image Platforms

1 Study Coverage
1.1 Clinical Trial Imaging Product Introduction
1.2 Market by Type
1.2.1 Global Clinical Trial Imaging Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 In-house Imaging Service
1.2.3 Central Imaging Service
1.3 Market by Application
1.3.1 Global Clinical Trial Imaging Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Pharmaceutical Companies
1.3.3 Biotechnology Companies
1.3.4 Academic Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Clinical Trial Imaging Market Size Estimates and Forecasts
2.2 Clinical Trial Imaging Market Size by Region: 2024 Versus 2031
2.2.1 Global Clinical Trial Imaging Revenue by Region: 2020-2025
2.2.2 Global Clinical Trial Imaging Revenue Forecast by Region (2026-2031)
2.2.3 Global Clinical Trial Imaging Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Clinical Trial Imaging Revenue by Type (2020-2031)
3.1.2 Global Clinical Trial Imaging Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Clinical Trial Imaging Revenue by Application (2020-2031)
3.2.2 Global Clinical Trial Imaging Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 In-house Imaging Service of Clinical Trial Imaging Revenue Market Share by Application
3.3.2 Central Imaging Service of Clinical Trial Imaging Revenue Market Share by Application
4 Global Clinical Trial Imaging by Company
4.1 Global Clinical Trial Imaging Revenue by Company (2020-2025)
4.2 Global Clinical Trial Imaging Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Clinical Trial Imaging Companies around the World: Ranking by Revenue
4.3.2 Global Clinical Trial Imaging Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Clinical Trial Imaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Clinical Trial Imaging Companies Headquarters & Product Type
4.4.1 Global Clinical Trial Imaging Companies Headquarters
4.4.2 Date of International Companies Enter into Clinical Trial Imaging Market
4.4.3 Global Clinical Trial Imaging Companies Product & Service
4.4.4 In-house Imaging Service Revenue Market Share of Clinical Trial Imaging by Company
4.4.5 Central Imaging Service Revenue Market Share of Clinical Trial Imaging by Company
4.5 Global Clinical Trial Imaging Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 ICON
5.1.1 ICON Corporation Information
5.1.2 ICON Description, Business Overview
5.1.3 ICON Clinical Trial Imaging Products Offered
5.1.4 ICON Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.1.5 ICON Clinical Trial Imaging Revenue by Product in 2024
5.1.6 ICON Clinical Trial Imaging Revenue by Application in 2024
5.1.7 ICON Clinical Trial Imaging Revenue by Geographic Area in 2024
5.1.8 ICON Recent Developments
5.2 ERT
5.2.1 ERT Corporation Information
5.2.2 ERT Description, Business Overview
5.2.3 ERT Clinical Trial Imaging Products Offered
5.2.4 ERT Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.2.5 ERT Clinical Trial Imaging Revenue by Product in 2024
5.2.6 ERT Clinical Trial Imaging Revenue by Application in 2024
5.2.7 ERT Clinical Trial Imaging Revenue by Geographic Area in 2024
5.2.8 ERT Recent Developments
5.3 McLaren
5.3.1 McLaren Corporation Information
5.3.2 McLaren Description, Business Overview
5.3.3 McLaren Clinical Trial Imaging Products Offered
5.3.4 McLaren Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.3.5 McLaren Clinical Trial Imaging Revenue by Product in 2024
5.3.6 McLaren Clinical Trial Imaging Revenue by Application in 2024
5.3.7 McLaren Clinical Trial Imaging Revenue by Geographic Area in 2024
5.3.8 McLaren Recent Developments
5.4 Bioclinica
5.4.1 Bioclinica Corporation Information
5.4.2 Bioclinica Description, Business Overview
5.4.3 Bioclinica Clinical Trial Imaging Products Offered
5.4.4 Bioclinica Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.4.5 Bioclinica Clinical Trial Imaging Revenue by Product in 2024
5.4.6 Bioclinica Clinical Trial Imaging Revenue by Application in 2024
5.4.7 Bioclinica Clinical Trial Imaging Revenue by Geographic Area in 2024
5.4.8 Bioclinica Recent Developments
5.5 Parexel
5.5.1 Parexel Corporation Information
5.5.2 Parexel Description, Business Overview
5.5.3 Parexel Clinical Trial Imaging Products Offered
5.5.4 Parexel Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.5.5 Parexel Clinical Trial Imaging Revenue by Product in 2024
5.5.6 Parexel Clinical Trial Imaging Revenue by Application in 2024
5.5.7 Parexel Clinical Trial Imaging Revenue by Geographic Area in 2024
5.5.8 Parexel Recent Developments
5.6 BioTelemetry
5.6.1 BioTelemetry Corporation Information
5.6.2 BioTelemetry Description, Business Overview
5.6.3 BioTelemetry Clinical Trial Imaging Products Offered
5.6.4 BioTelemetry Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.6.5 BioTelemetry Clinical Trial Imaging Revenue by Product in 2024
5.6.6 BioTelemetry Clinical Trial Imaging Revenue by Application in 2024
5.6.7 BioTelemetry Clinical Trial Imaging Revenue by Geographic Area in 2024
5.6.8 BioTelemetry Recent Developments
5.7 ProScan Imaging
5.7.1 ProScan Imaging Corporation Information
5.7.2 ProScan Imaging Description, Business Overview
5.7.3 ProScan Imaging Clinical Trial Imaging Products Offered
5.7.4 ProScan Imaging Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.7.5 ProScan Imaging Clinical Trial Imaging Revenue by Product in 2024
5.7.6 ProScan Imaging Clinical Trial Imaging Revenue by Application in 2024
5.7.7 ProScan Imaging Clinical Trial Imaging Revenue by Geographic Area in 2024
5.7.8 ProScan Imaging Recent Developments
5.8 Imaging Endpoints
5.8.1 Imaging Endpoints Corporation Information
5.8.2 Imaging Endpoints Description, Business Overview
5.8.3 Imaging Endpoints Clinical Trial Imaging Products Offered
5.8.4 Imaging Endpoints Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.8.5 Imaging Endpoints Clinical Trial Imaging Revenue by Product in 2024
5.8.6 Imaging Endpoints Clinical Trial Imaging Revenue by Application in 2024
5.8.7 Imaging Endpoints Clinical Trial Imaging Revenue by Geographic Area in 2024
5.8.8 Imaging Endpoints Recent Developments
5.9 Radiant Sage
5.9.1 Radiant Sage Corporation Information
5.9.2 Radiant Sage Description, Business Overview
5.9.3 Radiant Sage Clinical Trial Imaging Products Offered
5.9.4 Radiant Sage Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.9.5 Radiant Sage Clinical Trial Imaging Revenue by Product in 2024
5.9.6 Radiant Sage Clinical Trial Imaging Revenue by Application in 2024
5.9.7 Radiant Sage Clinical Trial Imaging Revenue by Geographic Area in 2024
5.9.8 Radiant Sage Recent Developments
5.10 Micron, Inc.
5.10.1 Micron, Inc. Corporation Information
5.10.2 Micron, Inc. Description, Business Overview
5.10.3 Micron, Inc. Clinical Trial Imaging Products Offered
5.10.4 Micron, Inc. Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.10.5 Micron, Inc. Clinical Trial Imaging Revenue by Product in 2024
5.10.6 Micron, Inc. Clinical Trial Imaging Revenue by Application in 2024
5.10.7 Micron, Inc. Clinical Trial Imaging Revenue by Geographic Area in 2024
5.10.8 Micron, Inc. Recent Developments
5.11 Intrinsic Imaging
5.11.1 Intrinsic Imaging Corporation Information
5.11.2 Intrinsic Imaging Description, Business Overview
5.11.3 Intrinsic Imaging Clinical Trial Imaging Products Offered
5.11.4 Intrinsic Imaging Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.11.5 Intrinsic Imaging Clinical Trial Imaging Revenue by Product in 2024
5.11.6 Intrinsic Imaging Clinical Trial Imaging Revenue by Application in 2024
5.11.7 Intrinsic Imaging Clinical Trial Imaging Revenue by Geographic Area in 2024
5.11.8 Intrinsic Imaging Recent Developments
5.12 Median Technologies
5.12.1 Median Technologies Corporation Information
5.12.2 Median Technologies Description, Business Overview
5.12.3 Median Technologies Clinical Trial Imaging Products Offered
5.12.4 Median Technologies Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.12.5 Median Technologies Clinical Trial Imaging Revenue by Product in 2024
5.12.6 Median Technologies Clinical Trial Imaging Revenue by Application in 2024
5.12.7 Median Technologies Clinical Trial Imaging Revenue by Geographic Area in 2024
5.12.8 Median Technologies Recent Developments
5.13 Cardiovascular Imaging Technologies
5.13.1 Cardiovascular Imaging Technologies Corporation Information
5.13.2 Cardiovascular Imaging Technologies Description, Business Overview
5.13.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Products Offered
5.13.4 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.13.5 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue by Product in 2024
5.13.6 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue by Application in 2024
5.13.7 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue by Geographic Area in 2024
5.13.8 Cardiovascular Imaging Technologies Recent Developments
5.14 Banook Medical
5.14.1 Banook Medical Corporation Information
5.14.2 Banook Medical Description, Business Overview
5.14.3 Banook Medical Clinical Trial Imaging Products Offered
5.14.4 Banook Medical Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.14.5 Banook Medical Clinical Trial Imaging Revenue by Product in 2024
5.14.6 Banook Medical Clinical Trial Imaging Revenue by Application in 2024
5.14.7 Banook Medical Clinical Trial Imaging Revenue by Geographic Area in 2024
5.14.8 Banook Medical Recent Developments
5.15 IXICO
5.15.1 IXICO Corporation Information
5.15.2 IXICO Description, Business Overview
5.15.3 IXICO Clinical Trial Imaging Products Offered
5.15.4 IXICO Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.15.5 IXICO Clinical Trial Imaging Revenue by Product in 2024
5.15.6 IXICO Clinical Trial Imaging Revenue by Application in 2024
5.15.7 IXICO Clinical Trial Imaging Revenue by Geographic Area in 2024
5.15.8 IXICO Recent Developments
5.16 Tigermed
5.16.1 Tigermed Corporation Information
5.16.2 Tigermed Description, Business Overview
5.16.3 Tigermed Clinical Trial Imaging Products Offered
5.16.4 Tigermed Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.16.5 Tigermed Clinical Trial Imaging Revenue by Product in 2024
5.16.6 Tigermed Clinical Trial Imaging Revenue by Application in 2024
5.16.7 Tigermed Clinical Trial Imaging Revenue by Geographic Area in 2024
5.16.8 Tigermed Recent Developments
5.17 Runda Medical
5.17.1 Runda Medical Corporation Information
5.17.2 Runda Medical Description, Business Overview
5.17.3 Runda Medical Clinical Trial Imaging Products Offered
5.17.4 Runda Medical Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.17.5 Runda Medical Clinical Trial Imaging Revenue by Product in 2024
5.17.6 Runda Medical Clinical Trial Imaging Revenue by Application in 2024
5.17.7 Runda Medical Clinical Trial Imaging Revenue by Geographic Area in 2024
5.17.8 Runda Medical Recent Developments
6 North America
6.1 North America Clinical Trial Imaging Market Size YoY Growth 2020-2031
6.2 North America Clinical Trial Imaging Market Facts & Figures by Country (2020-2031)
6.3 North America Clinical Trial Imaging Revenue by Type (2020-2025)
6.4 North America Clinical Trial Imaging Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Clinical Trial Imaging Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Clinical Trial Imaging Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Clinical Trial Imaging Revenue by Type (2020-2025)
7.4 Asia-Pacific Clinical Trial Imaging Revenue by Application (2020-2025)
8 Europe
8.1 Europe Clinical Trial Imaging Market Size YoY Growth 2020-2031
8.2 Europe Clinical Trial Imaging Market Facts & Figures by Country (2020-2031)
8.3 Europe Clinical Trial Imaging Revenue by Type (2020-2025)
8.4 Europe Clinical Trial Imaging Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Clinical Trial Imaging Market Size YoY Growth 2020-2031
9.2 Latin America Clinical Trial Imaging Market Facts & Figures by Country (2020-2031)
9.3 Latin America Clinical Trial Imaging Revenue by Type (2020-2025)
9.4 Latin America Clinical Trial Imaging Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Clinical Trial Imaging Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Clinical Trial Imaging Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Clinical Trial Imaging Revenue by Type (2020-2025)
10.4 Middle East and Africa Clinical Trial Imaging Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Clinical Trial Imaging Supply Chain Analysis
11.2 Clinical Trial Imaging Key Raw Materials and Upstream Suppliers
11.3 Clinical Trial Imaging Clients Analysis
11.4 Clinical Trial Imaging Sales Channel and Sales Model Analysis
11.4.1 Clinical Trial Imaging Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Clinical Trial Imaging Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Clinical Trial Imaging Distributors
12 Clinical Trial Imaging Market Dynamics
12.1 Clinical Trial Imaging Industry Trends
12.2 Clinical Trial Imaging Market Drivers
12.3 Clinical Trial Imaging Market Challenges
12.4 Clinical Trial Imaging Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
 Table 1. Global Clinical Trial Imaging Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Clinical Trial Imaging Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Clinical Trial Imaging Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Clinical Trial Imaging Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Clinical Trial Imaging Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Clinical Trial Imaging Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Clinical Trial Imaging Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Clinical Trial Imaging Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Clinical Trial Imaging Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Clinical Trial Imaging Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Clinical Trial Imaging Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Clinical Trial Imaging Players by Revenue (US$ Million) in 2024
 Table 13. Global Clinical Trial Imaging Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Clinical Trial Imaging by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Imaging as of 2024)
 Table 15. Global Clinical Trial Imaging Companies Headquarters
 Table 16. Date of International Companies Enter into Clinical Trial Imaging Market
 Table 17. Global Clinical Trial Imaging Companies Product & Service
 Table 18. Global Clinical Trial Imaging Mergers & Acquisitions, Expansion Plans
 Table 19. ICON Corporation Information
 Table 20. ICON Description and Business Overview
 Table 21. ICON Clinical Trial Imaging Product
 Table 22. ICON Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. ICON Revenue Proportion of Clinical Trial Imaging by Product in 2024
 Table 24. ICON Revenue Proportion of Clinical Trial Imaging by Application in 2024
 Table 25. ICON Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
 Table 26. ICON Recent Developments
 Table 27. ERT Corporation Information
 Table 28. ERT Description and Business Overview
 Table 29. ERT Clinical Trial Imaging Product
 Table 30. ERT Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. ERT Revenue Proportion of Clinical Trial Imaging by Product in 2024
 Table 32. ERT Revenue Proportion of Clinical Trial Imaging by Application in 2024
 Table 33. ERT Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
 Table 34. ERT Recent Developments
 Table 35. McLaren Corporation Information
 Table 36. McLaren Description and Business Overview
 Table 37. McLaren Clinical Trial Imaging Product
 Table 38. McLaren Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. McLaren Revenue Proportion of Clinical Trial Imaging by Product in 2024
 Table 40. McLaren Revenue Proportion of Clinical Trial Imaging by Application in 2024
 Table 41. McLaren Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
 Table 42. McLaren Recent Developments
 Table 43. Bioclinica Corporation Information
 Table 44. Bioclinica Description and Business Overview
 Table 45. Bioclinica Clinical Trial Imaging Product
 Table 46. Bioclinica Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Bioclinica Revenue Proportion of Clinical Trial Imaging by Product in 2024
 Table 48. Bioclinica Revenue Proportion of Clinical Trial Imaging by Application in 2024
 Table 49. Bioclinica Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
 Table 50. Bioclinica Recent Developments
 Table 51. Parexel Corporation Information
 Table 52. Parexel Description and Business Overview
 Table 53. Parexel Clinical Trial Imaging Product
 Table 54. Parexel Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. Parexel Revenue Proportion of Clinical Trial Imaging by Product in 2024
 Table 56. Parexel Revenue Proportion of Clinical Trial Imaging by Application in 2024
 Table 57. Parexel Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
 Table 58. Parexel Recent Developments
 Table 59. BioTelemetry Corporation Information
 Table 60. BioTelemetry Description and Business Overview
 Table 61. BioTelemetry Clinical Trial Imaging Product
 Table 62. BioTelemetry Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. BioTelemetry Revenue Proportion of Clinical Trial Imaging by Product in 2024
 Table 64. BioTelemetry Revenue Proportion of Clinical Trial Imaging by Application in 2024
 Table 65. BioTelemetry Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
 Table 66. BioTelemetry Recent Developments
 Table 67. ProScan Imaging Corporation Information
 Table 68. ProScan Imaging Description and Business Overview
 Table 69. ProScan Imaging Clinical Trial Imaging Product
 Table 70. ProScan Imaging Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. ProScan Imaging Revenue Proportion of Clinical Trial Imaging by Product in 2024
 Table 72. ProScan Imaging Revenue Proportion of Clinical Trial Imaging by Application in 2024
 Table 73. ProScan Imaging Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
 Table 74. ProScan Imaging Recent Developments
 Table 75. Imaging Endpoints Corporation Information
 Table 76. Imaging Endpoints Description and Business Overview
 Table 77. Imaging Endpoints Clinical Trial Imaging Product
 Table 78. Imaging Endpoints Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. Imaging Endpoints Revenue Proportion of Clinical Trial Imaging by Product in 2024
 Table 80. Imaging Endpoints Revenue Proportion of Clinical Trial Imaging by Application in 2024
 Table 81. Imaging Endpoints Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
 Table 82. Imaging Endpoints Recent Developments
 Table 83. Radiant Sage Corporation Information
 Table 84. Radiant Sage Description and Business Overview
 Table 85. Radiant Sage Clinical Trial Imaging Product
 Table 86. Radiant Sage Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. Radiant Sage Revenue Proportion of Clinical Trial Imaging by Product in 2024
 Table 88. Radiant Sage Revenue Proportion of Clinical Trial Imaging by Application in 2024
 Table 89. Radiant Sage Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
 Table 90. Radiant Sage Recent Developments
 Table 91. Micron, Inc. Corporation Information
 Table 92. Micron, Inc. Description and Business Overview
 Table 93. Micron, Inc. Clinical Trial Imaging Product
 Table 94. Micron, Inc. Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 95. Micron, Inc. Revenue Proportion of Clinical Trial Imaging by Product in 2024
 Table 96. Micron, Inc. Revenue Proportion of Clinical Trial Imaging by Application in 2024
 Table 97. Micron, Inc. Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
 Table 98. Micron, Inc. Recent Developments
 Table 99. Intrinsic Imaging Corporation Information
 Table 100. Intrinsic Imaging Description and Business Overview
 Table 101. Intrinsic Imaging Clinical Trial Imaging Product
 Table 102. Intrinsic Imaging Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Intrinsic Imaging Revenue Proportion of Clinical Trial Imaging by Product in 2024
 Table 104. Intrinsic Imaging Revenue Proportion of Clinical Trial Imaging by Application in 2024
 Table 105. Intrinsic Imaging Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
 Table 106. Intrinsic Imaging Recent Developments
 Table 107. Median Technologies Corporation Information
 Table 108. Median Technologies Description and Business Overview
 Table 109. Median Technologies Clinical Trial Imaging Product
 Table 110. Median Technologies Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 111. Median Technologies Revenue Proportion of Clinical Trial Imaging by Product in 2024
 Table 112. Median Technologies Revenue Proportion of Clinical Trial Imaging by Application in 2024
 Table 113. Median Technologies Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
 Table 114. Median Technologies Recent Developments
 Table 115. Cardiovascular Imaging Technologies Corporation Information
 Table 116. Cardiovascular Imaging Technologies Description and Business Overview
 Table 117. Cardiovascular Imaging Technologies Clinical Trial Imaging Product
 Table 118. Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 119. Cardiovascular Imaging Technologies Revenue Proportion of Clinical Trial Imaging by Product in 2024
 Table 120. Cardiovascular Imaging Technologies Revenue Proportion of Clinical Trial Imaging by Application in 2024
 Table 121. Cardiovascular Imaging Technologies Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
 Table 122. Cardiovascular Imaging Technologies Recent Developments
 Table 123. Banook Medical Corporation Information
 Table 124. Banook Medical Description and Business Overview
 Table 125. Banook Medical Clinical Trial Imaging Product
 Table 126. Banook Medical Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 127. Banook Medical Revenue Proportion of Clinical Trial Imaging by Product in 2024
 Table 128. Banook Medical Revenue Proportion of Clinical Trial Imaging by Application in 2024
 Table 129. Banook Medical Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
 Table 130. Banook Medical Recent Developments
 Table 131. IXICO Corporation Information
 Table 132. IXICO Description and Business Overview
 Table 133. IXICO Clinical Trial Imaging Product
 Table 134. IXICO Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 135. IXICO Revenue Proportion of Clinical Trial Imaging by Product in 2024
 Table 136. IXICO Revenue Proportion of Clinical Trial Imaging by Application in 2024
 Table 137. IXICO Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
 Table 138. IXICO Recent Developments
 Table 139. Tigermed Corporation Information
 Table 140. Tigermed Description and Business Overview
 Table 141. Tigermed Clinical Trial Imaging Product
 Table 142. Tigermed Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. Tigermed Revenue Proportion of Clinical Trial Imaging by Product in 2024
 Table 144. Tigermed Revenue Proportion of Clinical Trial Imaging by Application in 2024
 Table 145. Tigermed Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
 Table 146. Tigermed Recent Developments
 Table 147. Runda Medical Corporation Information
 Table 148. Runda Medical Description and Business Overview
 Table 149. Runda Medical Clinical Trial Imaging Product
 Table 150. Runda Medical Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 151. Runda Medical Revenue Proportion of Clinical Trial Imaging by Product in 2024
 Table 152. Runda Medical Revenue Proportion of Clinical Trial Imaging by Application in 2024
 Table 153. Runda Medical Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
 Table 154. Runda Medical Recent Developments
 Table 155. North America Clinical Trial Imaging Revenue by Country (2020-2025) & (US$ Million)
 Table 156. North America Clinical Trial Imaging Revenue by Country (2026-2031) & (US$ Million)
 Table 157. North America Clinical Trial Imaging Revenue by Type (2020-2025) & (US$ Million)
 Table 158. North America Clinical Trial Imaging Revenue by Application (2020-2025) & (US$ Million)
 Table 159. Asia-Pacific Clinical Trial Imaging Revenue by Region (2020-2025) & (US$ Million)
 Table 160. Asia-Pacific Clinical Trial Imaging Revenue by Region (2026-2031) & (US$ Million)
 Table 161. Asia-Pacific Clinical Trial Imaging Revenue by Type (2020-2025) & (US$ Million)
 Table 162. Asia-Pacific Clinical Trial Imaging Revenue by Application (2020-2025) & (US$ Million)
 Table 163. Europe Clinical Trial Imaging Revenue by Country (2020-2025) & (US$ Million)
 Table 164. Europe Clinical Trial Imaging Revenue by Country (2026-2031) & (US$ Million)
 Table 165. Europe Clinical Trial Imaging Revenue by Type (2020-2025) & (US$ Million)
 Table 166. Europe Clinical Trial Imaging Revenue by Application (2020-2025) & (US$ Million)
 Table 167. Latin America Clinical Trial Imaging Revenue by Country (2020-2025) & (US$ Million)
 Table 168. Latin America Clinical Trial Imaging Revenue by Country (2026-2031) & (US$ Million)
 Table 169. Latin America Clinical Trial Imaging Revenue by Type (2020-2025) & (US$ Million)
 Table 170. Latin America Clinical Trial Imaging Revenue by Application (2020-2025) & (US$ Million)
 Table 171. Middle East and Africa Clinical Trial Imaging Revenue by Country (2020-2025) & (US$ Million)
 Table 172. Middle East and Africa Clinical Trial Imaging Revenue by Country (2026-2031) & (US$ Million)
 Table 173. Middle East and Africa Clinical Trial Imaging Revenue by Type (2020-2025) & (US$ Million)
 Table 174. Middle East and Africa Clinical Trial Imaging Revenue by Application (2020-2025) & (US$ Million)
 Table 175. Clinical Trial Imaging Key Raw Materials, Industry Status and Trend
 Table 176. Clinical Trial Imaging Key Raw Materials and Upstream Suppliers
 Table 177. Clinical Trial Imaging Clients Status and Trend
 Table 178. Clinical Trial Imaging Typical Clients
 Table 179. Clinical Trial Imaging Distributors
 Table 180. Clinical Trial Imaging Market Trends
 Table 181. Clinical Trial Imaging Market Drivers
 Table 182. Clinical Trial Imaging Market Challenges
 Table 183. Clinical Trial Imaging Market Restraints
 Table 184. Research Programs/Design for This Report
 Table 185. Key Data Information from Secondary Sources
 Table 186. Key Data Information from Primary Sources


List of Figures
 Figure 1. Clinical Trial Imaging Product Picture
 Figure 2. Global Clinical Trial Imaging Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Clinical Trial Imaging Revenue Market Share by Type in 2024 & 2031
 Figure 4. In-house Imaging Service Product Picture
 Figure 5. Central Imaging Service Product Picture
 Figure 6. Global Clinical Trial Imaging Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Clinical Trial Imaging Revenue Market Share by Application in 2024 & 2031
 Figure 8. Pharmaceutical Companies
 Figure 9. Biotechnology Companies
 Figure 10. Academic Institutes
 Figure 11. Others
 Figure 12. Clinical Trial Imaging Report Years Considered
 Figure 13. Global Clinical Trial Imaging Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Clinical Trial Imaging Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Clinical Trial Imaging Market Size Market Share by Region: 2024 Versus 2031
 Figure 16. Global Clinical Trial Imaging Revenue Market Share by Region (2020-2031)
 Figure 17. Global Clinical Trial Imaging Revenue Market Share Forecast by Type (2020-2031)
 Figure 18. Global Clinical Trial Imaging Revenue Market Share Forecast by Application (2020-2031)
 Figure 19. In-house Imaging Service of Clinical Trial Imaging Revenue Market Share by Application, 2024 VS 2031
 Figure 20. Central Imaging Service of Clinical Trial Imaging Revenue Market Share by Application, 2024 VS 2031
 Figure 21. Clinical Trial Imaging Revenue Share by Company (2024)
 Figure 22. Clinical Trial Imaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. In-house Imaging Service Revenue Proportion by Company in 2024
 Figure 24. Central Imaging Service Revenue Proportion by Company in 2024
 Figure 25. North America Clinical Trial Imaging Revenue 2020-2031 (US$ Million)
 Figure 26. North America Clinical Trial Imaging Revenue Market Share by Type (2020-2025)
 Figure 27. North America Clinical Trial Imaging Revenue Market Share by Application (2020-2025)
 Figure 28. Asia-Pacific Clinical Trial Imaging Revenue 2020-2031 (US$ Million)
 Figure 29. Asia-Pacific Clinical Trial Imaging Revenue Market Share by Region (2020-2031)
 Figure 30. Asia-Pacific Clinical Trial Imaging Revenue Market Share by Type (2020-2025)
 Figure 31. Asia-Pacific Clinical Trial Imaging Revenue Market Share by Application (2020-2025)
 Figure 32. Europe Clinical Trial Imaging Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 33. Europe Clinical Trial Imaging Revenue Market Share by Country (2020-2031)
 Figure 34. Europe Clinical Trial Imaging Revenue Market Share by Type (2020-2025)
 Figure 35. Europe Clinical Trial Imaging Revenue Market Share by Application (2020-2025)
 Figure 36. Latin America Clinical Trial Imaging Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 37. Latin America Clinical Trial Imaging Revenue Market Share by Country (2020-2031)
 Figure 38. Latin America Clinical Trial Imaging Revenue Market Share by Type (2020-2025)
 Figure 39. Latin America Clinical Trial Imaging Revenue Market Share by Application (2020-2025)
 Figure 40. Middle East and Africa Clinical Trial Imaging Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 41. Middle East and Africa Clinical Trial Imaging Revenue Market Share by Country (2020-2031)
 Figure 42. Middle East and Africa Clinical Trial Imaging Revenue Market Share by Type (2020-2025)
 Figure 43. Middle East and Africa Clinical Trial Imaging Revenue Market Share by Application (2020-2025)
 Figure 44. Clinical Trial Imaging Supply Chain (Upstream and Downstream Market)
 Figure 45. Global Production Market Share of Clinical Trial Imaging Raw Materials by Region in 2024
 Figure 46. Clinical Trial Imaging Distribution Channels
 Figure 47. Global Clinical Trial Imaging Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 48. Global Clinical Trial Imaging Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 49. Bottom-up and Top-down Approaches for This Report
 Figure 50. Data Triangulation
 Figure 51. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI